Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Korosho's FY2003 Budget Request Totals \19,523.7 Bil., Up 4.58%
September 9, 2002
- Drug Industry Vision Finalized
September 9, 2002
- Telmisartan, Brinzolamide Recommended for Approval
September 9, 2002
- PAL Amendment Discussed: Jiho Seminar -2-
September 9, 2002
- PAL Amendment Discussed: Jiho Seminar
September 9, 2002
- JAPANESE LANGUAGE BOOKS
September 9, 2002
- WORLD NEWS IN BRIEF
September 9, 2002
- MEDICAL DEVICE NEWS IN BRIEF
September 9, 2002
- Website News
September 9, 2002
- DIAGNOSTIC NEWS IN BRIEF
September 9, 2002
- BULLETIN
September 9, 2002
- < Advertisement >
September 9, 2002
- 10 Wholesalers Have 108 Returns of Damaged Goods in 1 Year
September 9, 2002
- OTC NEWS IN BRIEF
September 9, 2002
- Hiring of New Graduates by Wholesalers Remains at Low Level: PJ Survey
September 9, 2002
- CORPORATE ROUNDUP NEWS IN BRIEF
September 9, 2002
- AstraZeneca Hires Largest Number of New Graduates in 2002: PJ Survey
September 9, 2002
- NEW PRODUCTS
September 9, 2002
- Hitachi High-Tech to Market bioMerieux's Blood Coagulation Products
September 2, 2002
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
September 2, 2002
ページ
Adeno-associated virus (AAV) gene therapies have long been viewed as carrying only a minimal risk of insertional mutagenesis — a…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…